Arrowhead Pharmaceuticals, Inc. (ARWR) vs Protagonist Therapeutics, Inc. (PTGX)
Arrowhead Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. are of similar size ($9.3B and $8.9B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 117×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 16.1%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −47.8%) and the higher return on invested capital (61.8% vs 0.00%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 12 and Arrowhead Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ARWR | PTGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (33.82%) | 20.69% | 0.00% |
| Net margin | (47.79%) | 29.40% | 0.00% |
| Free cash flow margin | (11.22%) | 46.31% | 0.00% |
| Return on equity | (64.91%) | 10.98% | (57.72%) |
| Return on assets | (18.32%) | 10.34% | (49.22%) |
| Return on invested capital | 0.00% | 61.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack